Novo Nordisk A/S lowered its financial forecast in a surprise update that cited lagging sales of its weight-loss drug Wegovy, as the company fights to regain its leading position in the obesity market ...

Novo Nordisk A/S promoted its head of international operations to become its new chief executive officer after a profit ...